chronic myelogenous leukemia

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))

Completed
  • Chronic Myelogenous Leukemia
  • imatinib mesilate
  • +2 more
  • Birmingham, Alabama
  • +162 more
Aug 7, 2013

Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)

Terminated
  • Chronic Myelogenous Leukemia
  • +4 more
  • CD8 Depleted Donor Lymphocyte
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 22, 2012

Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in Houston (Interleukin-11 (IL-11 or Neumega))

Completed
  • Leukemia
  • +2 more
  • Interleukin-11 (IL-11 or Neumega)
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 17, 2012

Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Chronic Myelogenous Leukemia Trial in Houston (Imatinib Mesylate

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Imatinib Mesylate (Gleevec)
  • PTK 787 (vatalanib)
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 19, 2012

Chronic Myelogenous Leukemia Trial in Houston (Busulfan, Cyclophosphamide, Imatinib Mesylate)

Completed
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 31, 2011

Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

Completed
  • Chronic Myelogenous Leukemia
  • Birmingham, Alabama
  • +69 more
Apr 13, 2011

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Oct 12, 2009

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Dec 12, 2007